A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.